Figures computed from official regulatory filings — methodology.
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
Create a free accountThis page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | |
|---|---|---|---|
| AwardD | $205.2K | SEC | |
| ExerciseD | $61.7K | SEC | |
| Exercise | $61.7K | SEC | |
| Exercise | $61.7K | SEC | |
| Buy | $10.8K | SEC | |
| Buy | $41.3K | SEC | |
| Buy | $2.8K | SEC | |
| Buy | $35.8K | SEC | |
| Buy | $3.3K | SEC | |
| Buy | $123.7K | SEC | |
| Buy | $44.7K | SEC | |
| Buy | $149.5K | SEC | |
| Buy | $2.9K | SEC | |
| Buy | $2.2K | SEC | |
| Buy | $97.8K | SEC | |
| Buy | $9.3K | SEC | |
| Buy | $1.5K | SEC | |
| Buy | $1.2K | SEC | |
| Buy | $25.3K | SEC | |
| Buy | $5.6K | SEC | |
| Buy | $27.8K | SEC | |
| Buy | $3.2K | SEC | |
| Buy | $1.5K | SEC | |
| Buy | $2.6K | SEC | |
| Buy | $2K | SEC |